CD8A and COVID-19: However, in contrast with HLA-A*02:01+ samples, even after multiple doses of the COVID-19 vaccine, the frequency of KCY+ naïve CD8+ T cells remained high, likely reflecting the large proportion of naïve T cells able to specifically bind the KCY peptide independent of vaccine status.